Prosecution Insights
Last updated: April 19, 2026

Examiner: ROGERS, JAMES WILLIAM

Tech Center 1600 • Art Units: 1618

This examiner grants 46% of resolved cases

Performance Statistics

46.4%
Allow Rate
-13.6% vs TC avg
941
Total Applications
+21.6%
Interview Lift
1400
Avg Prosecution Days
Based on 891 resolved cases, 2023–2026

Rejection Statute Breakdown

0.2%
§101 Eligibility
26.0%
§102 Novelty
41.5%
§103 Obviousness
22.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19218211 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19288889 CLEANSERS Final Rejection Dr. Squatch, LLC
18791288 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF Final Rejection Curium US LLC
17434132 RENAL CLEARABLE NANOPARTICLES AS EXOGENOUS MARKERS FOR EVALUATING KIDNEY FUNCTION Final Rejection Board of Regents, The University of Texas System
17614638 pH RESPONSIVE COMPOSITIONS AND USES THEREOF Final Rejection The Board of Regents of The University of Texas System
17744080 LOW MOLECULAR WEIGHT AND POLYAMIDOAMINE (PAMAM) DENDRIMER BASED PSMA-SPECIFIC DUAL CONTRAST AGENTS FOR OPTICAL AND PHOTOACOUSTIC IMAGING AND THERANOSTIC AGENTS FOR TREATING PROSTATE CANCER Final Rejection The Johns Hopkins University
16061908 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS Non-Final OA L'OREAL
18208672 PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE Non-Final OA University of Massachusetts
17997908 POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION Non-Final OA The Research Foundation for the State University of New York
18282705 ULTRASMALL GADOLINIUM-INTERCALATED CARBON DOTS AS A RADIOSENSITIZING AGENT FOR CANCER Non-Final OA UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
17790698 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING Final Rejection Oregon Health & Science University
17064352 INORGANIC NANOCAGES, AND METHODS OF MAKING AND USING SAME Final Rejection Cornell University
17898995 MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME Non-Final OA Rutgers, The State University of New Jersey
16707449 Method for Tuning Topology of Polymer Particles Non-Final OA UNIVERSITY OF SOUTH CAROLINA
17726296 COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER Final Rejection ACTINIUM PHARMACEUTICALS, INC.
17781731 CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY Final Rejection UNIVERSITÄT ZÜRICH
17778242 THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS Non-Final OA CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS
18460656 PHARMACEUTICAL COMPOSITION CONTAINING ETHANOL AND USE THEREOF Non-Final OA SUZHOU YIBEN LIFE TECHNOLOGY CO., LTD
18240138 ORTHOPEDIC ATTACHMENT SYSTEMS AND METHODS THEREOF Non-Final OA Anika Therapeutics, Inc.
17693262 CROSS-LINKED POLYMER MODIFIED NANOPARTICLES Final Rejection PDX Pharmaceuticals, Inc.
17754532 NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE Non-Final OA GUERBET
17665316 TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES Final Rejection Lithea AB
17414193 NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USING THE SAME Non-Final OA TIBA BIOTECH LLC
17924931 Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof Non-Final OA Institute of Process Engineering, Chinese Academy of Sciences
17787545 NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES Non-Final OA GE Healthcare AS
18054149 Methods of Noninvasive Detection and Specific Treatment for Cancer Metastasis Final Rejection Primo Biotechnology Co., Ltd
17922830 HEMOSTATIC POLYMER MATERIAL KIT Non-Final OA GELLYCLE CO., LTD.
18047181 FULLERENE AND ITS USE TO MAINTAIN GOOD HEALTH AND TO PROLONG THE EXPECTED LIFESPAN OF MAMMALS Final Rejection Fathi Moussa
17792336 COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE Final Rejection FLUOGUIDE A/S
17755671 pH Responsive Block Copolymers Compositions, Micelles, and Methods of Use Non-Final OA ONCONANO MEDICINE, INC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month